$CVRX
CVRx, Inc.

2022 Q4 Form 10-Q Financial Statement

#000155837022016432 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $7.176M $6.186M $3.395M
YoY Change 96.17% 82.21% 240.52%
Cost Of Revenue $1.509M $1.340M $876.0K
YoY Change 53.35% 52.97% 313.21%
Gross Profit $5.667M $4.846M $2.519M
YoY Change 111.93% 92.38% 220.89%
Gross Profit Margin 78.97% 78.34% 74.2%
Selling, General & Admin $14.10M $12.68M $8.111M
YoY Change 45.89% 56.32% 248.56%
% of Gross Profit 248.81% 261.64% 321.99%
Research & Development $3.046M $2.293M $1.699M
YoY Change 69.5% 34.96% 13.27%
% of Gross Profit 53.75% 47.32% 67.45%
Depreciation & Amortization $128.0K $127.0K $42.00K
YoY Change 128.57% 202.38% 147.06%
% of Gross Profit 2.26% 2.62% 1.67%
Operating Expenses $17.15M $14.97M $9.810M
YoY Change 49.59% 52.62% 156.34%
Operating Profit -$11.48M -$10.13M -$7.291M
YoY Change 30.62% 38.88% 139.68%
Interest Expense -$165.0K $0.00 $614.0K
YoY Change -58.33% -100.0% -1.13%
% of Operating Profit
Other Income/Expense, Net $1.136M $328.0K $1.795M
YoY Change -142.69% -81.73% 294.51%
Pretax Income -$10.51M -$9.798M -$6.110M
YoY Change -0.35% 60.36% 90.46%
Income Tax $28.00K $32.00K $23.00K
% Of Pretax Income
Net Earnings -$10.54M -$9.830M -$6.133M
YoY Change -0.32% 60.28% 90.05%
Net Earnings / Revenue -146.82% -158.91% -180.65%
Basic Earnings Per Share -$0.48 -$0.30
Diluted Earnings Per Share -$511.6K -$0.48 -$317.9K
COMMON SHARES
Basic Shares Outstanding 20.58M 20.58M 20.35M
Diluted Shares Outstanding 20.58M 20.13M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.2M $110.0M $170.9M
YoY Change -25.25% -35.65%
Cash & Equivalents $106.2M $110.0M $170.9M
Short-Term Investments
Other Short-Term Assets $4.223M $3.066M $2.923M
YoY Change 63.37% 4.89%
Inventory $6.957M $6.064M $3.440M
Prepaid Expenses
Receivables $5.504M $5.297M $3.421M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $122.9M $124.4M $180.7M
YoY Change -18.68% -31.15%
LONG-TERM ASSETS
Property, Plant & Equipment $2.032M $1.747M $943.0K
YoY Change 42.6% 85.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.00K $26.00K $67.00K
YoY Change 3.85% -61.19%
Total Long-Term Assets $2.059M $2.164M $1.010M
YoY Change 41.9% 114.26%
TOTAL ASSETS
Total Short-Term Assets $122.9M $124.4M $180.7M
Total Long-Term Assets $2.059M $2.164M $1.010M
Total Assets $124.9M $126.6M $181.7M
YoY Change -18.1% -30.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.719M $1.276M $541.0K
YoY Change 237.06% 135.86%
Accrued Expenses $6.369M $6.120M $4.977M
YoY Change 17.99% 22.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.333M
YoY Change
Total Short-Term Liabilities $8.088M $7.396M $8.851M
YoY Change 36.9% -16.44%
LONG-TERM LIABILITIES
Long-Term Debt $6.747M $0.00 $16.15M
YoY Change -100.0%
Other Long-Term Liabilities $922.0K $761.0K $941.0K
YoY Change 35.39% -19.13%
Total Long-Term Liabilities $7.669M $761.0K $17.09M
YoY Change 1026.14% -95.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.088M $7.396M $8.851M
Total Long-Term Liabilities $7.669M $761.0K $17.09M
Total Liabilities $15.76M $8.332M $25.94M
YoY Change 139.14% -67.88%
SHAREHOLDERS EQUITY
Retained Earnings -$436.2M -$425.6M -$384.2M
YoY Change 10.49% 10.79%
Common Stock $545.6M $544.1M $540.1M
YoY Change 0.86% 0.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $109.2M $118.2M $155.8M
YoY Change
Total Liabilities & Shareholders Equity $124.9M $126.6M $181.7M
YoY Change -18.1% -30.34%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$10.54M -$9.830M -$6.133M
YoY Change -0.32% 60.28% 90.05%
Depreciation, Depletion And Amortization $128.0K $127.0K $42.00K
YoY Change 128.57% 202.38% 147.06%
Cash From Operating Activities -$10.84M -$11.10M -$9.215M
YoY Change 54.54% 20.41% 78.69%
INVESTING ACTIVITIES
Capital Expenditures $79.00K -$264.0K -$165.0K
YoY Change -114.68% 60.0% 39.83%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$79.00K -$264.0K -$165.0K
YoY Change -85.32% 60.0% 39.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.117M 7.000K 133.2M
YoY Change -133.43% -99.99% 167.5%
NET CHANGE
Cash From Operating Activities -10.84M -11.10M -9.215M
Cash From Investing Activities -79.00K -264.0K -165.0K
Cash From Financing Activities 7.117M 7.000K 133.2M
Net Change In Cash -3.803M -11.35M 123.8M
YoY Change -86.81% -109.17% 178.13%
FREE CASH FLOW
Cash From Operating Activities -$10.84M -$11.10M -$9.215M
Capital Expenditures $79.00K -$264.0K -$165.0K
Free Cash Flow -$10.92M -$10.83M -$9.050M
YoY Change 68.6% 19.69% 79.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.66
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2560000
CY2022Q3 us-gaap Inventory Net
InventoryNet
6064000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3880000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20512254
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6975386
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3066000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2585000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20576838
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20126672
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20512254
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6975386
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20576838
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20126672
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.66
dei Entity Central Index Key
EntityCentralIndexKey
0001235912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20578963
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20399337
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.025
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40545
dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
dei City Area Code
CityAreaCode
763
dei Local Phone Number
LocalPhoneNumber
416-2840
dei Security12b Title
Security12bTitle
Common stock,
dei Trading Symbol
TradingSymbol
CVRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20584163
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109985000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142072000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5297000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
124412000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
151097000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1747000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5398000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1425000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
391000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2022Q3 us-gaap Assets
Assets
126576000
CY2021Q4 us-gaap Assets
Assets
152548000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1276000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6120000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7396000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5908000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
175000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
761000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
681000
CY2022Q3 us-gaap Liabilities
Liabilities
8332000
CY2021Q4 us-gaap Liabilities
Liabilities
6589000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20578963
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20399337
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
206000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
204000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
543903000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
540707000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-425646000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394754000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-219000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
118244000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126576000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152548000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6186000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3395000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15293000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9378000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1340000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
876000
us-gaap Cost Of Revenue
CostOfRevenue
3490000
us-gaap Cost Of Revenue
CostOfRevenue
2656000
CY2022Q3 us-gaap Gross Profit
GrossProfit
4846000
CY2021Q3 us-gaap Gross Profit
GrossProfit
2519000
us-gaap Gross Profit
GrossProfit
11803000
us-gaap Gross Profit
GrossProfit
6722000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2293000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1699000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6906000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5704000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12679000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8111000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35945000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18198000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
14972000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
9810000
us-gaap Operating Expenses
OperatingExpenses
42851000
us-gaap Operating Expenses
OperatingExpenses
23902000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10126000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7291000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31048000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17180000
CY2021Q3 us-gaap Interest Expense
InterestExpense
614000
us-gaap Interest Expense
InterestExpense
1823000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
328000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1795000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
237000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13439000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9798000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6110000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30811000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32442000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6133000
us-gaap Net Income Loss
NetIncomeLoss
-30892000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9838000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6136000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30913000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32516000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.66
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20576838
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20126672
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20512254
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6975386
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
929000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
118244000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-318931000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
474000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
133161000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
1000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
347188000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6133000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
155763000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
81000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2822000
us-gaap Net Income Loss
NetIncomeLoss
-30892000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
118244000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-293238000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1159000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
133161000
us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
1000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
347188000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
155763000
us-gaap Profit Loss
ProfitLoss
-30892000
us-gaap Profit Loss
ProfitLoss
-32508000
us-gaap Share Based Compensation
ShareBasedCompensation
2822000
us-gaap Share Based Compensation
ShareBasedCompensation
1159000
us-gaap Depreciation
Depreciation
284000
us-gaap Depreciation
Depreciation
112000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
206000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
13294000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2737000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2140000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2184000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
97000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
479000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2359000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
766000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
58000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
81000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
584000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1558000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31836000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20717000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
606000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
645000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-606000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-645000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
295000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
cvrx Payments Related To Reverse Stock Split
PaymentsRelatedToReverseStockSplit
0
cvrx Payments Related To Reverse Stock Split
PaymentsRelatedToReverseStockSplit
1000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
133161000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
376000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133170000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-21000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32087000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
111801000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142072000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59112000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109985000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170913000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
1522000
us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.17
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2139000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1593000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
917000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
482000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3008000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1805000
CY2022Q3 us-gaap Inventory Net
InventoryNet
6064000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3880000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3899000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3293000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2152000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1868000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1747000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1425000
CY2022Q3 us-gaap Depreciation
Depreciation
127000
CY2021Q3 us-gaap Depreciation
Depreciation
42000
us-gaap Depreciation
Depreciation
284000
us-gaap Depreciation
Depreciation
112000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
929000
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2048000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2028000
CY2022Q3 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1808000
CY2021Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1607000
CY2022Q3 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
853000
CY2021Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
699000
CY2022Q3 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
370000
CY2021Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
380000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
218000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
823000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
684000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6120000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5398000
CY2021Q3 cvrx Fair Value Level1 To Level2 To Level3 Transfers Amount
FairValueLevel1ToLevel2ToLevel3TransfersAmount
0
CY2022Q3 cvrx Fair Value Level1 To Level2 To Level3 Transfers Amount
FairValueLevel1ToLevel2ToLevel3TransfersAmount
0
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
391000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
218000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
175000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
393000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
58000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
234000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
119000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
411000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
393000
CY2022Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P1Y9M18D
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.050
us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2022Q3 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
39.548
CY2021Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11929584
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2749441
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1406783
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
310780
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.56
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
121945
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.67
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3723499
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10623000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
474000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6975386
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1547838
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.96
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7581000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2822000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1159000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
929000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
474000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2822000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1159000
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6133000
us-gaap Net Income Loss
NetIncomeLoss
-30892000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20576838
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20126672
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20512254
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4439630
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.66
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3373464
CY2022Q3 us-gaap Contractual Obligation
ContractualObligation
0
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6186000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3395000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15293000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9378000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-22-016432-index-headers.html Edgar Link pending
0001558370-22-016432-index.html Edgar Link pending
0001558370-22-016432.txt Edgar Link pending
0001558370-22-016432-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220930.xsd Edgar Link pending
tmb-20220930x10q.htm Edgar Link pending
tmb-20220930xex31d1.htm Edgar Link pending
tmb-20220930xex31d2.htm Edgar Link pending
tmb-20220930xex32d1.htm Edgar Link pending
tmb-20220930xex32d2.htm Edgar Link pending
tmb-20220930_cal.xml Edgar Link unprocessable
tmb-20220930_def.xml Edgar Link unprocessable
tmb-20220930_pre.xml Edgar Link unprocessable
tmb-20220930_lab.xml Edgar Link unprocessable
tmb-20220930x10q_htm.xml Edgar Link completed